(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-04-25 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1283030
Date | Daily Closing Price | Open | High | Low | Volume |
25 Thu Apr 2024 | 53.73 | 53.98 | 54.15 | 52.75 | 0.973 times |
24 Wed Apr 2024 | 55.65 | 56.79 | 57.78 | 55.50 | 0.717 times |
23 Tue Apr 2024 | 56.41 | 55.93 | 58.68 | 55.56 | 0.928 times |
22 Mon Apr 2024 | 55.66 | 55.40 | 56.93 | 54.37 | 0.814 times |
19 Fri Apr 2024 | 55.05 | 56.16 | 57.50 | 54.28 | 1.377 times |
18 Thu Apr 2024 | 56.16 | 55.86 | 58.03 | 55.25 | 1.36 times |
17 Wed Apr 2024 | 55.56 | 58.34 | 58.47 | 55.52 | 1.091 times |
16 Tue Apr 2024 | 57.96 | 58.04 | 58.74 | 57.14 | 0.917 times |
15 Mon Apr 2024 | 58.72 | 60.74 | 60.95 | 58.47 | 1.144 times |
12 Fri Apr 2024 | 60.67 | 62.23 | 62.35 | 60.25 | 0.841 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 56.1, but if it comes above 56.1, then a intra day buy could be more profitable.
If you take a sell trade below 56.1, then use 56.1 as stoploss and 50.6 as target. However if you take a buy trade in stock , then use 56.1 as stoploss and 60.67 as target.
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 52.75 |
Upside Target | 54.28 |
Upside Target | 58.29 |
Upside Target | 60.25 |
Upside Target | 65.24 |
Upside Target | 67.52 |
Upside Target | 68.39 |
Upside Target | 68.48 |
Upside Target | 73.09 |
Upside Target | 76.97 |
Upside Target | 87.08 |
Upside Target | 91.10 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 51.43 |
Downside Intraday Target | 49.12 |
Upside Intraday Target | 57.36 |
Upside Intraday Target | 60.98 |
Upside Intraday Target | 55.05 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Thu Apr 2024 | 53.73 | 55.40 | 58.68 | 52.75 | 0.583 times |
19 Fri Apr 2024 | 55.05 | 60.74 | 60.95 | 54.28 | 1.213 times |
12 Fri Apr 2024 | 60.67 | 63.21 | 65.24 | 60.25 | 0.962 times |
05 Fri Apr 2024 | 62.90 | 68.14 | 68.39 | 62.33 | 1.381 times |
28 Thu Mar 2024 | 68.16 | 71.55 | 73.09 | 67.52 | 0.743 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Thu Apr 2024 | 53.73 | 68.14 | 68.39 | 52.75 | 0.912 times |
28 Thu Mar 2024 | 68.16 | 84.36 | 87.08 | 67.52 | 0.53 times |
29 Thu Feb 2024 | 84.22 | 63.49 | 91.10 | 62.08 | 1.159 times |
31 Wed Jan 2024 | 62.95 | 61.84 | 68.48 | 58.29 | 0.571 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.48 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.48 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.